Innovation Pharmaceuticals Inc (IPIX)

[garydaemon]

Amgen has an updated patent for AMG900

And within this patent:

The invention also includes use of any other pre-clinical HDAC inhibitors, including without limitation, Kevetrin, an agent selective for HDAC2, that are later determined to be useful for the treatment of cancer via the reduction or inhibition of histone deacetylase activity in combination with AMG 900.

Interesting if they are studying Kevetrin

They do have a study with Vorinostat out.

CONCLUSIONS: These results indicate that AMG 900 may be a promising drug for the adjuvant treatment of MB (Medulloblastoma), mainly when combined with iHDAC.
http://www.ncbi.nlm.nih.gov/pubmed/26000978